A STAT Investigation

A STAT Investigation Jared Whitlock

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

A STAT Investigation Casey Ross

Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans

A STAT Investigation Olivia Goldhill

Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid

A STAT Investigation Katie Palmer

Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

A STAT Investigation Olivia Goldhill

A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens

A STAT Investigation Usha Lee McFarling

The whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlier

A STAT Investigation Rachel Cohrs

How America’s largest Catholic hospital system is moonlighting as a private equity firm

A STAT Investigation Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

A STAT Investigation Megan Molteni and Mario Aguilar

Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment

A STAT Investigation Casey Ross

Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why

A STAT Investigation Casey Ross

Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients

A STAT Investigation Olivia Goldhill

‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients

A STAT Investigation Eric Boodman

Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic

A STAT Investigation Casey Ross and Mario Aguilar

Inside the fall of Watson Health: How IBM’s audacious plan to ‘change the face of health care’ with AI fell apart

A STAT Investigation Casey Ross

Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern

A STAT Investigation Casey Ross

As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness

Casey Ross and Erin Brodwin

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

A STAT Investigation Kathleen McLaughlin

HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns

A STAT Investigation Casey Ross

From a small town in North Carolina to big-city hospitals, how software infuses racism into U.S. health care

Politics Lev Facher

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

A STAT Investigation Casey Ross and Erin Brodwin

Hospitals turn to big tech companies to store and analyze their data — leaving patients in the dark on privacy protections

A STAT Investigation Megan Thielking

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

Politics Talia Bronshtein

Nerd’s notes: How we did the ClinicalTrials.gov data analysis

A STAT Investigation Charles Piller and Talia Bronshtein

Faced with public pressure, research institutions step up reporting of clinical trial results

Exclusive Damian Garde

A STAT Investigation

Most Read

What will it take to level the playing field for Black residents?

‘It was stolen from me’: Black doctors are forced out of training programs at far higher rates than white residents

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

FDA’s breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies

AI gone astray: How subtle shifts in patient data send popular algorithms reeling, undermining patient safety

Watch: A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field

Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?

‘Health equity tourists’: How white scholars are colonizing research on health disparities

All Coverage

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans

Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid

Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens

The whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlier

How America’s largest Catholic hospital system is moonlighting as a private equity firm

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment

Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why

Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients

‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients

Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic

Inside the fall of Watson Health: How IBM’s audacious plan to ‘change the face of health care’ with AI fell apart

Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern

As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns

From a small town in North Carolina to big-city hospitals, how software infuses racism into U.S. health care

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

Hospitals turn to big tech companies to store and analyze their data — leaving patients in the dark on privacy protections

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

Nerd’s notes: How we did the ClinicalTrials.gov data analysis

Faced with public pressure, research institutions step up reporting of clinical trial results

Biotech hedge fund titan Sam Isaly harassed, demeaned women for years, former employees say

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day